The company intends to use the funding to advance its AI-powered microscopy system for infectious disease analysis.
The collaboration combines Guardant's diagnostics with Trial Library's AI-powered matching and patient navigation platform.
The company intends to use the funding to advance its AI-powered microscopy system for infectious disease analysis.
With the approval, the company's automated clinical mass spec system, the Cobas I 601 analyzer, features an in vitro diagnostic menu of 39 tests.